MannKind | MNKD - Ebitda





Ebitda Cambio Fecha
Adma Biologics USD 55.44M 5.62M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -64.54M 34.34M 2026-06
MannKind USD 2.47M 461K 2026-06
Merck USD 1.42B 2.97B 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Novo Nordisk DKK 37.36B 31.84B 2026-06
Pfizer USD 6.36B 350M 2026-09
Sanofi EUR 5.79B 2.1B 2026-09
Xencor USD 25.1M 59.73M 2026-09